Skip to main navigation
AvidXchange logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Corporate Governance
    • Our Environmental, Social, Governance (ESG) commitment
    • Governance Overview
    • Leadership
    • Committee Composition
  • Financial Info
    • SEC Filings
  • Shareholder Services
    • Investor FAQs
    • Contact Us

Investor Relations

Corporate Profile

GreenLight aims to solve some of the world's largest and most difficult problems by delivering on the full potential of RNA.
Environmental, Social, Governance (ESG) responsibilities are core to this purpose.

 

Latest news releases

Featured Releases

05.10.22
GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award
03.29.22
Co-developer of COVID-19 Vaccine Joins GreenLight Advisory Board
03.14.22
GreenLight Biosciences Holdings, PBC (GRNA) enters into multitarget licensing agreement with Serum Institute of India to develop and commercialize messenger RNA products for emerging markets globally
  • View All News
Latest events

Events

01.20.22
Analyst teach-in (plant and animal health) - January 20th 2022
12.08.21
Analyst teach-in (health and platform) - December 8th 2021
  • View All Events
Latest earnings

SEC Filings

Filing date Form
03.31.22 10-K
03.26.21 10-K
05.16.22 10-Q
  • View All Filings

 

To stay updated with GreenLight news

Sign Up

Shareholder Tools

What we do

  • Platform
  • Human Health
  • Plant and Animal Health

Quick links

  • Careers
  • Contact
  • Partners
  • Press kit

Join us on Social

  • LinkedIn
  • Twitter

Footer Bottom

  • Privacy Policy
  • All rights reserved. 2022 GreenLight Biosciences